Intervention

EPA

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting0

Common conditions9

Lead sponsors shown4

Clinical trials

4 shown

Impact of Smoking Information on Concerns About RadonNCT03499535 · 2015-08-07

COMPLETED

Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeNCT02333435 · 2015-02-12

ACTIVE_NOT_RECRUITING

The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild DementiaNCT04972643 · 2012-09-23

COMPLETED

Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to BehaviourNCT02615405 · 2012-08-01

COMPLETED

Common conditions

Alzheimer Disease1 Dementia Disorder1 Intention1 Lung Neoplasms1 Major Depressive Disorder1 Prostate Cancer1 Radon Exposure1 Risk Reduction Behavior1 Smoking1

Leading sponsors

CHU de Quebec-Universite Laval1 National Science and Technology Council, Taiwan1 Paul Windschitl1 Taichung Veterans General Hospital1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING1

Phase mix

NA3

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.